You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 7, 2025

Drug Price Trends for NDC 33342-0153


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 33342-0153

Drug Name NDC Price/Unit ($) Unit Date
VARDENAFIL HCL 10 MG TABLET 33342-0153-07 3.01800 EACH 2024-12-18
VARDENAFIL HCL 10 MG TABLET 33342-0153-07 3.64412 EACH 2024-11-20
VARDENAFIL HCL 10 MG TABLET 33342-0153-07 3.38825 EACH 2024-10-23
VARDENAFIL HCL 10 MG TABLET 33342-0153-07 2.48439 EACH 2024-09-18
VARDENAFIL HCL 10 MG TABLET 33342-0153-07 3.91270 EACH 2024-07-17
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NDC 33342-0153

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

33342-0153 Market Analysis and Financial Projection

Market Analysis and Price Projections for Drug NDC: 33342-0153

Understanding NDC Codes

To begin with, it's crucial to understand what an NDC (National Drug Code) is. The NDC is a unique 11-digit code assigned to each medication, including the labeler code, product code, and package code. The NDC 33342-0153 identifies a specific drug product, but to analyze its market and price projections, we need to identify the drug it corresponds to.

Identifying the Drug

The NDC 33342-0153 can be looked up in the FDA's NDC Directory or other pharmaceutical databases to determine the specific drug it represents. For example, using the FDA's NDC Directory, you can search by the NDC number to find details such as the proprietary name, non-proprietary name, dosage form, route of administration, and other relevant information[4].

Market Analysis

Pharmaceutical Market Trends

The pharmaceutical market is dynamic and influenced by various factors, including regulatory changes, new drug approvals, patent expirations, and market competition.

  • Regulatory Compliance: Drugs must comply with regulatory requirements, such as those outlined by the CMS for reporting payments and NDCs. This ensures that manufacturers report new NDCs promptly to facilitate coverage under Medicaid programs[2].

  • Market Segmentation: The pharmaceutical market can be segmented by product type, application, and geographic region. For instance, the NSCLC (Non-Small Cell Lung Cancer) market is expected to grow significantly due to the introduction of immunotherapies and targeted therapies[3].

Specific Drug Market Analysis

Assuming the NDC 33342-0153 corresponds to a specific drug, here are some general steps to analyze its market:

  • Competitive Landscape: Identify the competitors in the same therapeutic class. For example, in the NSCLC market, drugs like Keytruda, Opdivo, and Tecentriq dominate the immunotherapy segment[3].

  • Sales Projections: Analyze historical sales data and market trends to project future sales. For instance, the NSCLC market is projected to reach $26.8 billion by 2025, driven by the uptake of premium-priced immunotherapies and targeted therapies[3].

  • Pricing Strategies: Understand the pricing dynamics of the drug. Manufacturers often adjust prices based on market conditions, competition, and regulatory requirements. For example, warranty payment arrangements can affect the best price calculations for Medicaid rebates[2].

Price Projections

Factors Influencing Pricing

Several factors influence the pricing of pharmaceuticals:

  • Patent Expirations: The expiration of patents can lead to the introduction of generics, which can significantly reduce the price of the original drug. For example, the patent expiration of Tarceva and Alimta has led to a decline in their sales and an increase in generic sales[3].

  • Market Competition: Increased competition from similar drugs can drive prices down. In the NSCLC market, the launch of new immunotherapies and targeted therapies has intensified competition, affecting pricing strategies[3].

  • Regulatory Requirements: Compliance with regulatory requirements, such as reporting NDCs and average manufacturer prices (AMPs), can impact pricing. Manufacturers must ensure timely reporting to maintain compliance and avoid penalties[2].

Pricing Models

Pricing models can vary, including:

  • Value-Based Pricing: This model ties the price of the drug to its clinical or performance outcomes. For example, warranty payment arrangements where manufacturers pay premiums to warrant the drug's performance can influence pricing[2].

  • Competitive Pricing: Prices are set based on what competitors are charging for similar products. In a competitive market like NSCLC, prices are often adjusted to remain competitive while maintaining profitability[3].

Example: NSCLC Market Pricing

To illustrate, let's consider the NSCLC market:

  • Immunotherapies: Drugs like Keytruda, Opdivo, and Tecentriq are priced premium due to their efficacy and market demand. By 2025, these drugs are projected to account for $17.5 billion in sales, with Keytruda alone expected to contribute $5.2 billion[3].

  • Targeted Therapies: Drugs like Tagrisso and Avastin also command high prices due to their targeted mechanisms and clinical outcomes. Tagrisso, for instance, is projected to achieve $1.7 billion in sales by 2025[3].

Key Takeaways

  • Regulatory Compliance: Timely reporting of NDCs and compliance with regulatory requirements are crucial for maintaining market presence and avoiding penalties.
  • Market Trends: Understanding market trends, such as the rise of immunotherapies and targeted therapies, is essential for projecting sales and pricing.
  • Pricing Strategies: Pricing models such as value-based pricing and competitive pricing are key in determining the price of pharmaceuticals.
  • Competitive Landscape: Analyzing the competitive landscape helps in understanding the positioning and pricing of a specific drug.

FAQs

Q: What is the significance of the NDC Directory in pharmaceutical market analysis? A: The NDC Directory is a critical resource for validating drug information, including the proprietary name, dosage form, and package details, which is essential for reporting payments and ensuring compliance with regulatory requirements[1][4].

Q: How do patent expirations affect drug pricing? A: Patent expirations lead to the introduction of generics, which can significantly reduce the price of the original drug. For example, the patent expiration of Tarceva and Alimta has led to a decline in their sales and an increase in generic sales[3].

Q: What role do warranty payment arrangements play in drug pricing? A: Warranty payment arrangements can influence pricing by requiring manufacturers to pay premiums to warrant the drug's performance. These premiums are included in the best price calculations for Medicaid rebates[2].

Q: How does market competition impact drug pricing? A: Increased competition from similar drugs can drive prices down. In competitive markets like NSCLC, prices are often adjusted to remain competitive while maintaining profitability[3].

Q: What are the key factors influencing pharmaceutical pricing? A: Key factors include patent expirations, market competition, regulatory requirements, and the adoption of new pricing models such as value-based pricing[2][3].

Sources

  1. CMS: Drug Name and National Drug Code (NDC) Reference Data Instructions Calendar Year 2024.
  2. Medicaid: Manufacturer Release 118.
  3. GlobalData: NSCLC MARKET - Global Drug Forecast & Market Analysis to 2025.
  4. FDA: NDC Directory (March 2015) - YouTube.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.